Lifecare ASA

LIFE Lifecare CEO presents at Redeye Growth Day 2024

Bergen, Norway, 30 May 2024: Today, at 13:00 CEST Lifecare CEO Joacim Holter

will participate at Redeye Growth Day 2024 and present the latest development

of the company.

******

Lifecare ASA is a clinical stage medical sensor company developing technology

for sensing and monitoring of various body analytes. Lifecare's main focus is

to bring the next generation of Continuous Glucose Monitoring ("CGM") systems

to market.

Lifecare enables osmotic pressure as sensing principle, combined with the

ability to manipulate Nano-granular Tunnelling Resistive sensors ("NTR") on

the sensor body for read-out of pressure variations. Lifecare s sensor

technology is referred to as "Sencell" and is suitable for identifying and

monitoring the occurrence of a wide range of analytes and molecules in the

human body and in pets.

The presentation is live broadcasted and can be followed at

https://www.redeye.se/events/981085/redeye-growth-day-2024 where the replay

and the presentations will be available afterwards.

About us

Lifecare ASA is a clinical stage medical sensor company developing technology

for sensing and monitoring of various body analytes. Lifecare's main focus is

to bring the next generation of Continuous Glucose Monitoring ("CGM") systems

to market. Lifecare enables osmotic pressure as sensing principle, combined

with the ability to manipulate Nano-granular Tunnelling Resistive sensors

("NTR") on the sensor body for read-out of pressure variations. Lifecare's

sensor technology is referred to as "Sencell" and is suitable for identifying

and monitoring the occurrence of a wide range of analytes and molecules in the

human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, [email protected], +47 40 05 90 40

Renete Kaarvik, CFO, [email protected], +47 94 83 82 42

AI Terminal